[HTML][HTML] Microbial-based therapies in the treatment of inflammatory bowel disease–an overview of human studies

PJ Basso, NOS Câmara… - Frontiers in pharmacology, 2019 - frontiersin.org
Inflammatory bowel disease (IBD) is a group of multifactorial and inflammatory infirmities
comprised of two main entities: Ulcerative colitis (UC) and Crohn's disease (CD). Classic …

[HTML][HTML] Manipulating microbiota in inflammatory bowel disease treatment: Clinical and natural product interventions explored

M Zhu, Y Song, Y Xu, H Xu - International journal of molecular sciences, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is a complex multifactorial chronic inflammatory disease,
that includes Crohn's disease (CD) and ulcerative colitis (UC), having progressively …

The role of the gut microbiota in the treatment of inflammatory bowel diseases

I Aggeletopoulou, C Konstantakis… - Microbial …, 2019 - Elsevier
The human intestinal microbiota coevolves with its host through a symbiotic relationship and
exerts great influence on substantial functions including aspects of physiology, metabolism …

[HTML][HTML] Intestinal microbiota: the explosive mixture at the origin of inflammatory bowel disease?

R Bringiotti, E Ierardi, R Lovero, G Losurdo… - World journal of …, 2014 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs), namely Crohn's disease and ulcerative colitis, are
lifelong chronic disorders arising from interactions among genetic, immunological and …

Microbial-based and microbial-targeted therapies for inflammatory bowel diseases

A Oka, RB Sartor - Digestive diseases and sciences, 2020 - Springer
Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
pouchitis, are chronic, relapsing intestinal inflammatory disorders mediated by dysregulated …

[HTML][HTML] Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?

A Nishida, K Nishino, K Sakai, Y Owaki… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract encompassing two main clinical entities, Crohn's disease and ulcerative colitis …

Current understanding of microbiota-and dietary-therapies for treating inflammatory bowel disease

T Eom, YS Kim, CH Choi, MJ Sadowsky, T Unno - Journal of Microbiology, 2018 - Springer
Inflammatory bowel disease (IBD) is a result of chronic inflammation caused, in some part,
by dysbiosis of intestinal microbiota, mainly commensal bacteria. Gut dysbiosis can be …

Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases

M Schultz, J Schölmerich, HC Rath - Digestive Diseases, 2003 - karger.com
Inflammatory bowel diseases (IBD), commonly referred to as Crohn's disease and ulcerative
colitis are chronic aggressive disorders which share many similarities concerning …

[HTML][HTML] Highlighting the relevance of gut microbiota manipulation in inflammatory bowel disease

FM Pavel, CM Vesa, G Gheorghe, CC Diaconu… - Diagnostics, 2021 - mdpi.com
Two different conditions are included in inflammatory bowel disease (IBD), Crohn's disease
(CD) and ulcerative colitis (UC), being distinguished by chronic recurrence of gut …

Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation

R Wu, R Xiong, Y Li, J Chen, R Yan - Journal of Autoimmunity, 2023 - Elsevier
Gut dysbiosis has been associated with inflammatory bowel disease (IBD), one of the most
common gastrointestinal diseases. The microbial communities play essential roles in host …